Provepharm Inc.: Drug Recall
Recall #D-0150-2025 · 11/22/2024
Class II: Risk
Recall Details
- Recall Number
- D-0150-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Provepharm Inc.
- Status
- Ongoing
- Date Initiated
- 11/22/2024
- Location
- Collegeville, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2160 packs/5 ampules per pack = 10,800 ampules
Reason for Recall
Discoloration
Product Description
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
Distribution Pattern
Nationwide within the United States
Other Recalls by Provepharm Inc.
- Class I: Dangerous 01/21/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.